Kaia Health gets $75M on rising interest in its virtual treatments for persistent discomfort and COPD

New York headquartered Kaia Health, which offers AI-assisted digital therapies by means of a mobile app for persistent discomfort related to musculoskeletal (MSK) conditions and for Chronic Obstructive Lung Disease (COPD), has actually raised a $75 million Series C. The round was led by an unnamed leading growth equity fund with support from existing investors, including Optum Ventures, […] In the United States Kaia focuses on activation rate as a percentage of the company population — — and Mehl says this stands between 5%-10%, depending on how the app is interacted to possible users. In February it kicked off a major combination of its patient-facing MSK therapy/pain-management app with a referral system that plugs into services used by other health care providers — — using an escalation algorithm and screening and triage system, which it calls Kaia Entrance — — to recognize clients at threat of needing more intrusive or extreme treatment than the digital treatments its app can supply. “And also work with external medical companies — — physicians etc — and bring our users at the best point to the best physician to avoid any degeneration in pain that we can not deal with in the app. While, for Kaia, it’s deeply focused on building tech to deal with a few specific illness — and so, also, isn’t best suited to basic medical service shipment.

Better Health raises $3.5 M seed round to transform medical supply shopping through e-commerce

Better Health raises $3.5 M seed round to transform medical supply shopping through e-commerce

The home medical supply market in the U.S. is considerable and growing, however the way that Americans go about getting much-needed medical supplies, particularly for those with persistent conditions, relies on out-of-date and clumsy sales systems that frequently have really poor consumer experiences. New start-up Better Health intends to alter that, with an e-commerce approach […] Better Health estimates the total worth of the house medical materials market in the U.S., which covers all reimbursable gadgets and supplies needed for persistent conditions, including things like colostomy bags, catheters, movement help, insulin pumps and more, is around $60 billion each year. In the process of bringing it to market, I was exposed to the medical gadgets and materials industry. Unlike in the prescription drug market, where your choices basically amount to whether you select the brand name or the generic, and the outcome is pretty much the same regardless, in medical materials which option you pick can have a significantly different effect on your experience. Already, Better Health is a Medicare-licensed supplier in 48 states, and it has partnerships in place with commercial suppliers like Humana and Oscar Health.

How Rani Therapeutics’ robotic pill could alter subcutaneous injection treament

How Rani Therapeutics’ robotic pill could alter subcutaneous injection treament

A new auto-injecting pill may soon end up being a replacement for subcutaneous injection treatments. The idea for this so-called robotic tablet came out of a research task around 8 years earlier from InCube Labs– a life sciences laboratory run by Rani Therapeutics Chairman and CEO Mir Imran, who has degrees in electrical and biomedical engineering from Rutgers […] In working on the technology behind San Jose-based Rani Rehabs, Imran and his team wanted to discover a method to ease some of the agonizing side impacts of subcutaneous (or under-the-skin) injections, while likewise enhancing the treatment’s efficacy. One of Imran’s priorities for the pill was to remove the unpleasant side impacts of subcutaneous injections. “It wouldn’t make sense to replace them with another unpleasant injection,” he stated. Imran and his group have plans to use the tablet for a range of signs, consisting of the development hormone condition acromegaly, diabetes, and osteoporosis. …

Medtech start-up uMotif raises ₤ 5M from AlbionVC, as COVID-19 accelerates remote medical studies

Medtech start-up uMotif raises ₤ 5M from AlbionVC, as COVID-19 accelerates remote medical studies

Medtech startup uMotif has an app that permits clients to monitor themselves for treatments or drug trials, which then feeds into a platform, enabling a much faster method to medical research studies. It has actually now raised ₤ 5 million in a Series A financial investment round led by existing U.K. financier AlbionVC, with participation from Oslo-based DNV-GL and […] It has actually now raised ₤ 5 million in a Series An investment round led by existing U.K. investor AlbionVC, with involvement from Oslo-based DNV-GL and existing angel financiers. The platform is now used by research studies taking place in 26 nations, from medical to real-world settings, and across more than 25 restorative locations– from dermatology and rare disease to oncology and cardiology. …

Kaia Health gets $26M to show it can do more with digital therapeutics

Kaia Health gets $26M to show it can do more with digital therapeutics

Kaia Health, a digital therapies startup which uses computer system vision technology for real-time posture tracking through the mobile phone electronic camera to provide human-hands-free physiotherapy, has actually closed a $26 million Series B funding round. The financing was led by Optum Ventures, Idinvest and capital300 with involvement from existing financiers Balderton Capital and Heartcore Capital, in addition to […] “We right now have 9 scientific research studies continuous– part of the studies have the objective to compare our treatment apps against a lot of care treatments,” he goes on, fleshing out the reason for having such a strong focus on research study. “We we began 4.5 years ago it was quite unsexy to start something in digital therapies and now there are so many startups getting begun for digital treatments or digital health.”The crucial thing here is we never create any therapy– we simply digitize the best in class treatment and that’s important because if not you have really different requirements of what you have to prove,” he adds. To have this full treatment path in the digital world simply became mass market now. …

Lucid Lane has established a service to get patients off of pain medications and avoid dependency

Lucid Lane has established a service to get patients off of pain medications and avoid dependency

4 years back, Adnan Asar, the founder of the brand-new addiction avoidance service Lucid Lane, was delighting in an effective career working as the starting chief innovation officer at Livongo Health. It was the serial senior tech executive’s latest task after a long stint at Shutterfly and he was shepherding the company through the advancement […] “My other half decided to go cold turkey,” Asar said. It took 9 months of therapy and routine consultations with psychiatrists to help with customizing medication dosages and tapering to get her off of the medication, stated Asar. “COVID-19 has actually made telehealth a compulsory service instead of a discretionary service,” said Asar.”We see fantastic prospective for Lucid Lane, as it has developed a scalable solution to one of the biggest issues facing society today,” said Battery general partner Dharmesh Thakker, in a statement. …